Et. Lee et al., Follow-up of the WHO multinational study of vascular disease in diabetes: general description and morbidity, DIABETOLOG, 44, 2001, pp. S3-S13
Aims. The incidence of retinal, renal and cardiovascular complications and
their relation to baseline risk factors was documented in this follow-up st
udy of 10 of the 14 original centres of the WHO Multinational Study of Vasc
ular Disease in Diabetes (WHO MSVDD).
Methods. The incidence of specified items of vascular disease and some asso
ciated risk factors was ascertained after 7 to 9 years (11-12 years in Okla
homa, USA) follow-up, re-using baseline examination methodology in 3165 pat
ients (66.9%) and, through secondary information in 717 (15.2%) of the 4729
original patients, of whom 540 (11.4%) had died and 307 (6.5%) were untrac
eable.
Results. During follow-up, approximately one third of the patients develope
d hypertension and one third started insulin. Coronary heart disease incide
nce varied 10 to 20-fold among centres as did limb amputation rates. Inter-
centre differences in incident retinopathy and severe visual impairment wer
e smaller but incident clinical proteinuria and renal failure varied marked
ly. Vascular disease incidence of all categories was high in Native America
ns though coronary heart disease incidence was relatively low in Pima India
ns and absolutely low in Hong Kong and Tokyo patients. Specific vascular ev
ents and their relation with baseline risk factors are analysed in accompan
ying papers, summarised in the Epilogue.
Conclusion/interpretation. These 10 centres reported very different inciden
ce rates of vascular complications. Observer variation, selection biases an
d competing causes of mortality contributed to these differences but their
validity is supported by the more objective outcome indicators. The followi
ng papers also suggest that baseline factors such as raised arterial pressu
re, cholesterol and fasting glucose (in the centres where it was measured)
were important and potentially reversible predictors of risk.